Safety evaluation of cleansing foam or facial sunscreen for acne vulgaris patients
- Conditions
- Acne vulgaris
- Registration Number
- JPRN-UMIN000020936
- Lead Sponsor
- Shiba Palace Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 24
1)Japanese females aged from 20 to 50 years old at the time informed consent was provided
2)Count of 1-20 acne lesions (pimples) on the right or left half of the face
3)Patients who provided written informed consent to change from their everyday use of cleanser or facial sunscreen to the test agent during the study period
?Patients with severe or greater acne vulgaris
?Patients receiving systemic administration of a drug for a purpose other than acne vulgaris therapy
?Patients receiving a topically administered drug on the face for a purpose other than acne vulgaris therapy
?Pregnant women, those who may be pregnant, lactating women, or women who hope to become pregnant during the study period
?Patients for whom the test agent is contraindicated
?Patients who were considered inappropriate for the study by an investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of dermatological assessment and questionnaire before and after the repeated use of cleansing foam or facial sunscreen for 1 and 4 weeks
- Secondary Outcome Measures
Name Time Method Blood test, measurement of transepidermal water loss (TEWL) and skin moisture